{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P48431",
      "entity_text" : "Sox2",
      "entity_type" : "gene"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:10090" ],
      "TissueType" : [ "tissuelist:TS-1025" ],
      "Organ" : [ "uberon:UBERON:0000104" ],
      "CellType" : [ "cl:CL:0002248" ]
    }
  },
  "verbose_text" : "While treatment with metformin significantly reduces pluripotent stem cells markers, Oct4 and Ssea-1, with more limited effects on the expression of Sox2 and Nanog, treatment with the AMPK activator 5-aminoimidazole-4-carboxyamide ribonucleoside (AICAR) also markedly inhibits proliferation of ES cells and enhances erythroid differentiation by significantly reducing Nanog and Ssea-1 but without affecting expression of Oct4 XREF_BIBR.",
  "reading_complete" : "2020-07-28T18:31:49Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T18:29:57Z",
  "trigger" : "expression",
  "evidence" : [ "expression of Sox2" ],
  "pmc_id" : "3520055",
  "score" : 0
}